首站-论文投稿智能助手
典型文献
Clinical potential of tension-lengthening strategies during nerve repair
文献摘要:
A (very) brief history of tension in nerve repair: Successful nerve repair is achieved by conveying as many axons successfully to their targets as possible. Typically, this is best achieved through a direct end-to-end repair under minimal tension (Millesi, 1986). However, this is not feasible in most cases of trauma, where a segment of tissue damage must be excised and overcome. This has most commonly been addressed with the use of nerve grafts to bridge the gap. Autologous nerve grafts are considered the gold standard, with allograft or synthetic substitutes demonstrating some success over shorter distances. Despite their utility, autologous grafts pose challenges of their own. These include functional deficit in the donor distribution (typically sensory), extended operative duration, additional scarring, and a lack of intrinsic blood supply. They are also a poor anatomical match for the stumps being bridged, both internally (disparate neuronal size and composition) as well as externally (often requiring cabled bundles to approximate the caliber of the nerve being repaired). Finally, unlike end-to-end repairs, autologous grafts also require axons to traverse a second repair interface, where a large proportion of axons are lost across the anatomical discontinuity.
文献关键词:
作者姓名:
Stanley Bazarek
作者机构:
Department of Neurosurgery,Massachusetts General Hospital/Harvard Medical School,Boston,MA,USA;Department of Neurosurgery,Brigham&Women's Hospital/Harvard Medical School,Boston,MA,USA;Departments of Orthopedic Surgery and Bioengineering,University of California-San Diego,La Jolla,CA,USA
引用格式:
[1]Stanley Bazarek-.Clinical potential of tension-lengthening strategies during nerve repair)[J].中国神经再生研究(英文版),2022(04):779-780
A类:
Millesi,stumps,cabled
B类:
Clinical,potential,tension,lengthening,strategies,during,nerve,very,brief,history,Successful,achieved,by,conveying,many,axons,successfully,their,targets,possible,Typically,this,best,through,direct,under,minimal,However,not,feasible,most,cases,trauma,where,segment,tissue,damage,must,excised,overcome,This,has,commonly,been,addressed,use,grafts,gap,Autologous,are,considered,gold,standard,allograft,synthetic,substitutes,demonstrating,some,shorter,distances,Despite,utility,autologous,pose,challenges,own,These,include,functional,deficit,donor,distribution,typically,sensory,extended,operative,duration,additional,scarring,lack,intrinsic,blood,supply,They,also,poor,anatomical,match,being,bridged,both,internally,disparate,neuronal,size,composition,well,externally,often,requiring,bundles,approximate,caliber,repaired,Finally,unlike,repairs,require,traverse,second,interface,large,proportion,lost,across,discontinuity
AB值:
0.661493
相似文献
TRDMT1 exhibited protective effects against LPS - induced inflammation in rats through TLR4- NF- κB / MAPK- TNF - α pathway
Zhengguang Li;Xiaolong Qi;Xu Zhang;Lei Yu;Lijuan Gao;Weining Kong;Wei Chen;Wei Dong;Lijun Luo;Dan Lu;Lianfeng Zhang;Yuanwu Ma-Key Laboratory of Human Disease Comparative Medicine,National Health Commission of China(NHC),Institute of Laboratory Animal Science,Chinese Academy of Medical Sciences,Peking Union Medicine College,Beijing,China;National Human Diseases Animal Model Resource Center and Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases,Institute of Laboratory Animal Science,Peking Union Medicine College,Chinese Academy of Medical Sciences,Beijing,China;Neuroscience Center,Chinese Academy of Medical Sciences,Beijing,China
A randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients
Zheng Xiang;Zhang Weijie;Zhou Hua;Cao Ronghua;Shou Zhangfei;Zhang Shuwei;Cheng Ying;Chen Xuchun;Ding Chenguang;Tang Zuofu;Li Ning;Shi Shaohua;Zhou Qiang;Chen Qiuyuan;Chen Gang;Chen Zheng;Zhou Peijun;Hu Xiaopeng;Zhang Xiaodong;Na Ning;Wang Wei-Department of Urology, Capital Medical University Beijing Chaoyang Hospital, Beijing 100020, China;Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430032, China;Kidney Transplantation Dialysis Center, The Second People’s Hospital of Shanxi Province, Taiyuan, Shanxi 030012, China;Department of Organ Transplantation, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong 510120, China;Department of Nephrology, Shulan (Hangzhou) Hospital, Hangzhou, Zhejiang 310000, China;Department of Urology, Ningbo Yinzhou Number. 2 Hospital, Ningbo, Zhejiang 315000, China;Department of Organ Transplantation, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, China;Institute of Kidney Transplantation, The First Affiliated Hospital, Medical College of Xi’an Jiaotong University, Xi’an, Shaanxi 710061, China;Department of Kidney, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510630, China;Department of Kidney, Southwest Hospital, The First Hospital Affiliated to The Third Military Medical University (Army Medical University), Chongqing 400000, China;Organ Transplant Center, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510260, China;Kidney Transplantation Center, Department of Urology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200000, China
Structural basis of the activation of metabotropic glutamate receptor 3
Wei Fang;Fan Yang;Chanjuan Xu;Shenglong Ling;Li Lin;Yingxin Zhou;Wenjing Sun;Xiaomei Wang;Peng Liu;Philippe Rondard;Pan Shi;Jean-Philippe Pin;Changlin Tian;Jianfeng Liu-The First Affiliated Hospital of USTC,School of Life Sciences,Division of Life Sciences and Medicine,Joint Center for Biological Analytical Chemistry,Anhui Engineering Laboratory of Peptide Drug,Anhui Laboratory of Advanced Photonic Science and Technology,University of Science and Technology of China,Hefei,Anhui,China;Key Laboratory of Molecular Biophysics of MOE,International Research Center for Sensory Biology and Technology of MOST,College of Life Science and Technology,Huazhong University of Science and Technology(HUST),Wuhan,Hubei,China;Bioland Laboratory,Guangzhou Regenerative Medicine and Health Guangdong Laboratory,Guangzhou,Guangdong,China;Institut de Génomique Fonctionnelle(IGF),Université de Montpellier,CNRS,INSERM,Montpellier,France
Treatment of autosomal recessive hearing loss via in vivo CRISPR/Cas9-mediated optimized homology-directed repair in mice
Xi Gu;Xinde Hu;Daqi Wang;Zhijiao Xu;Fang Wang;Di Li;Geng-lin Li;Hui Yang;Huawei Li;Erwei Zuo;Yilai Shu-ENT institute and Department of Otorhinolaryngology,Eye & ENT Hospital,State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science,Fudan University,Shanghai,China;Institutes of Biomedical Sciences,Fudan University,Shanghai,China;Department of Otolaryngology,the First Affiliated Hospital of Fujian Medical University,Fuzhou,China;NHC Key Laboratory of Hearing Medicine(Fudan University),Shanghai,China;Institute of Neuroscience,State Key Laboratory of Neuroscience,Key Laboratory of Primate Neurobiology,CAS Center for Excellence in Brain Science and Intelligence Technology,Shanghai Research Center for Brain Science and Brain-Inspired Intelligence,Shanghai Institutes for Biological Sciences,Chinese Academy of Sciences,Shanghai,China;State Key Lab for Conservation and Utilization of Subtropical Agric-Biological Resources,Guangxi University,Nanning,China;Shenzhen Branch,Guangdong Laboratory for Lingnan Modern Agriculture,Genome Analysis Laboratory of the Ministry of Agriculture,Agricultural Genomics Institute at Shenzhen,Chinese Academy of Agricultural Sciences,Shenzhen,China;The Institutes of Brain Science and the Collaborative Innovation Center for Brain Science,Fudan University,Shanghai,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。